Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Levenguc reported for 2023 by IFRS

17:38 LVHK

Tatneft reported for 3 months of 2024 by RAS

17:13 TATN

M.Video launched the retailer's first multi-brand smartphone zones

17:08 MVID

Levenguc reported for 3 months of 2024 by RAS

15:41 LVHK

MTS reported for 2023 by RAS

15:05 MTSS

NPO Nauka reported for 3 months of 2024 by RAS

14:48 NAUK

NPO Nauka reported for 2023 by IFRS

14:46 NAUK

Mosgorlombard set the date of conversion of preferred shares

13:26 MGKL

Board of Directors of Sollers recommended that dividends be paid for 2023

13:06 SVAV

Abrau-Durso reported for 3 months of 2024 by RAS

13:03 ABRD